To support organisations in establishing a robust risk assessment process for new homecare medicines services the NHMC has developed a tool for local use. …
NPPG and RCPCH strongly recommend that when children require unlicensed liquid medications, they should receive the RCPCH- and NPPG- recommended strength, where one exists. There…
Developed from the well-known STOPP medication review tool, STOPIT has helped pharmacists and doctors in NW London to systematically review continuing medication in individuals who…
Valproate containing medicines are indicated for the treatment of epilepsy, bipolar disorder and migraine headache (unlicensed). Valproate is known to be highly teratogenic and use…
We aimed to make self-administration more easily available to patients who wanted it. We conducted a failure, modes and effects analysis, collected baseline data on…
In March 2018 NHMC approved a list of standard service areas which will be incorporated into version 6 of the national KPI dataset. Homecare providers…
The Homecare Service Proposal (HSP) Form is to be completed by pharmaceutical manufacturers where there are new homecare medicines services or where there are changes…
This document provides a framework of good practice for pharmacy and medicines optimisation in readiness for managing winter pressures in the acute hospital sector and…
In November 2016, the Royal Pharmaceutical Society (RPS) published Appendix 19 of the Royal Pharmaceutical Society (RPS) Handbook for Homecare Services in England i.e. ‘Further…
At its meeting on 18th April 2018 the Regional Medicines Optimisation Committee (RMOC) (Midlands and East) reviewed issues pertaining to safety considerations when adopting any…